Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Krystal Biotech, Inc. (KRYS) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Krystal Biotech, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1711279.
Total stock buying since 2017: $5,957,387.
Total stock sales since 2017: $235,416,238.
Total stock option exercises since 2017: $6,142,376.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 129,004 | $22,165,669 | 167,500 | $0 |
| 2024 | 0 | $0 | 450,587 | $79,229,315 | 97,500 | $2,626,389 |
| 2023 | 0 | $0 | 758,128 | $77,865,213 | 62,500 | $3,454,425 |
| 2022 | 0 | $0 | 173,956 | $14,010,110 | 0 | $0 |
| 2021 | 0 | $0 | 300,000 | $21,150,000 | 0 | $0 |
| 2020 | 0 | $0 | 215,398 | $11,141,973 | 0 | $0 |
| 2019 | 0 | $0 | 188,684 | $9,853,958 | 6,250 | $61,562 |
| 2018 | 136,800 | $1,957,387 | 0 | $0 | 0 | $0 |
| 2017 | 400,000 | $4,000,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 28,254 | $4,260,254 | 0 | $0 |
| 2025-03 | 0 | $0 | 100,000 | $17,774,000 | 0 | $0 |
| 2025-02 | 0 | $0 | 750 | $131,415 | 167,500 | $0 |
| 2024-12 | 0 | $0 | 100,000 | $16,711,098 | 0 | $0 |
| 2024-09 | 0 | $0 | 100,000 | $19,843,300 | 0 | $0 |
| 2024-06 | 0 | $0 | 100,000 | $17,495,400 | 0 | $0 |
| 2024-05 | 0 | $0 | 20,000 | $3,292,040 | 20,000 | $455,000 |
| 2024-03 | 0 | $0 | 100,000 | $17,110,900 | 0 | $0 |
| 2024-02 | 0 | $0 | 28,087 | $4,451,577 | 75,000 | $2,040,739 |
| 2024-01 | 0 | $0 | 2,500 | $325,000 | 2,500 | $130,650 |
| 2023-12 | 0 | $0 | 100,000 | $10,583,900 | 0 | $0 |
| 2023-09 | 0 | $0 | 100,000 | $12,721,000 | 0 | $0 |
| 2023-06 | 0 | $0 | 62,500 | $8,035,917 | 12,500 | $794,375 |
| 2023-05 | 0 | $0 | 220,528 | $23,394,722 | 50,000 | $2,660,050 |
| 2023-04 | 0 | $0 | 107,900 | $9,459,096 | 0 | $0 |
| 2023-03 | 0 | $0 | 40,000 | $3,329,960 | 0 | $0 |
| 2023-01 | 0 | $0 | 127,200 | $10,340,618 | 0 | $0 |
| 2022-12 | 0 | $0 | 170,374 | $13,723,390 | 0 | $0 |
| 2022-11 | 0 | $0 | 3,582 | $286,720 | 0 | $0 |
| 2021-12 | 0 | $0 | 300,000 | $21,150,000 | 0 | $0 |
| 2020-09 | 0 | $0 | 50,000 | $2,331,834 | 0 | $0 |
| 2020-06 | 0 | $0 | 50,000 | $2,163,900 | 0 | $0 |
| 2020-05 | 0 | $0 | 50,000 | $2,901,591 | 0 | $0 |
| 2020-03 | 0 | $0 | 15,398 | $631,752 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-10 | Krishnan Suma (President, R&D) | Sale | 13,727 | 150.80 | 2,070,086 |
| 2025-07-10 | Krishnan Krish S (President and CEO) | Sale | 13,727 | 150.80 | 2,070,086 |
| 2025-07-09 | Krishnan Suma (President, R&D) | Sale | 400 | 150.10 | 60,041 |
| 2025-07-09 | Krishnan Krish S (President and CEO) | Sale | 400 | 150.10 | 60,041 |
| 2025-03-13 | Krishnan Suma (President, R&D) | Sale | 50,000 | 177.74 | 8,887,000 |
| 2025-03-13 | Krishnan Krish S (President and CEO) | Sale | 50,000 | 177.74 | 8,887,000 |
| 2025-02-28 | Romano Kathryn (Chief Accounting Officer) | Option Ex | 12,500 | .00 | 0 |
| 2025-02-28 | Krishnan Suma (President, R&D) | Option Ex | 77,500 | .00 | 0 |
| 2025-02-28 | Krishnan Krish S (President and CEO) | Option Ex | 77,500 | .00 | 0 |
| 2025-02-27 | Romano Kathryn (Chief Accounting Officer) | Sale | 750 | 175.22 | 131,415 |
| 2024-12-13 | Krishnan Suma (President, R&D) | Sale | 50,000 | 167.11 | 8,355,549 |
| 2024-12-13 | Krishnan Krish S (President and CEO) | Sale | 50,000 | 167.11 | 8,355,549 |
| 2024-09-12 | Krishnan Suma (President, R&D) | Sale | 50,000 | 198.43 | 9,921,650 |
| 2024-09-12 | Krishnan Krish S (President and CEO) | Sale | 50,000 | 198.43 | 9,921,650 |
| 2024-06-11 | Krishnan Suma (President, R&D) | Sale | 50,000 | 174.95 | 8,747,700 |
| 2024-06-11 | Krishnan Krish S (President and CEO) | Sale | 50,000 | 174.95 | 8,747,700 |
| 2024-05-20 | Gangolli Julian S (Director) | Sale | 20,000 | 164.60 | 3,292,040 |
| 2024-05-20 | Gangolli Julian S (Director) | Option Ex | 20,000 | 22.75 | 455,000 |
| 2024-03-11 | Krishnan Suma (President, R&D) | Sale | 50,000 | 171.11 | 8,555,450 |
| 2024-03-11 | Krishnan Krish S (President and CEO) | Sale | 50,000 | 171.11 | 8,555,450 |
| 2024-02-28 | Romano Kathryn (Chief Accounting Officer) | Sale | 12,500 | 167.00 | 2,087,385 |
| 2024-02-28 | Romano Kathryn (Chief Accounting Officer) | Option Ex | 17,500 | 60.02 | 1,041,515 |
| 2024-02-28 | Krishnan Suma (President, R&D) | Option Ex | 20,000 | .00 | 0 |
| 2024-02-28 | Krishnan Krish S (President and CEO) | Option Ex | 20,000 | .00 | 0 |
| 2024-02-27 | Romano Kathryn (Chief Accounting Officer) | Option Ex | 1,913 | 52.26 | 99,973 |
| 2024-02-26 | Romano Kathryn (Chief Accounting Officer) | Sale | 8,087 | 137.50 | 1,111,962 |
| 2024-02-26 | Romano Kathryn (Chief Accounting Officer) | Option Ex | 8,087 | 52.26 | 422,626 |
| 2024-01-22 | Romano Kathryn (Chief Accounting Officer) | Sale | 2,500 | 130.00 | 325,000 |
| 2024-01-22 | Romano Kathryn (Chief Accounting Officer) | Option Ex | 2,500 | 52.26 | 130,650 |
| 2023-12-11 | Krishnan Suma (President, R&D) | Sale | 50,000 | 105.84 | 5,291,950 |
| 2023-12-11 | Krishnan Krish S (President and CEO) | Sale | 50,000 | 105.84 | 5,291,950 |
| 2023-09-11 | Krishnan Suma (President, R&D) | Sale | 50,000 | 127.21 | 6,360,500 |
| 2023-09-11 | Krishnan Krish S (President and CEO) | Sale | 50,000 | 127.21 | 6,360,500 |
| 2023-06-09 | Orth Andrew C. (Chief Commercial Officer) | Sale | 12,500 | 128.91 | 1,611,437 |
| 2023-06-09 | Orth Andrew C. (Chief Commercial Officer) | Option Ex | 12,500 | 63.55 | 794,375 |
| 2023-06-09 | Janney Daniel (Director) | Sale | 18,935 | 128.89 | 2,440,456 |
| 2023-06-08 | Janney Daniel (Director) | Sale | 31,065 | 128.25 | 3,984,024 |
| 2023-05-31 | Krishnan Suma (President, R&D) | Sale | 50,000 | 116.83 | 5,841,350 |
| 2023-05-31 | Krishnan Krish S (President and CEO) | Sale | 50,000 | 116.83 | 5,841,350 |
| 2023-05-22 | Romano Kathryn (Chief Accounting Officer) | Sale | 25,000 | 108.28 | 2,706,900 |
| 2023-05-22 | Romano Kathryn (Chief Accounting Officer) | Option Ex | 25,000 | 54.14 | 1,353,550 |
| 2023-05-19 | Romano Kathryn (Chief Accounting Officer) | Sale | 28,428 | 95.06 | 2,702,337 |
| 2023-05-19 | Romano Kathryn (Chief Accounting Officer) | Option Ex | 25,000 | 52.26 | 1,306,500 |
| 2023-05-19 | Janney Daniel | Sale | 50,000 | 95.02 | 4,751,200 |
| 2023-05-09 | Janney Daniel | Sale | 17,100 | 90.74 | 1,551,585 |
| 2023-04-19 | Janney Daniel | Sale | 7,900 | 90.32 | 713,496 |
| 2023-04-17 | Krishnan Suma (President, R&D) | Sale | 50,000 | 87.46 | 4,372,800 |
| 2023-04-17 | Krishnan Krish S (President and CEO) | Sale | 50,000 | 87.46 | 4,372,800 |
| 2023-03-01 | Rossi Dino A | Sale | 40,000 | 83.25 | 3,329,960 |
| 2023-01-18 | Krishnan Suma (President, R&D) | Sale | 5,703 | 81.16 | 462,832 |
| 2023-01-18 | Krishnan Krish S (President and CEO) | Sale | 5,703 | 81.16 | 462,832 |
| 2023-01-17 | Krishnan Suma (President, R&D) | Sale | 44,297 | 81.61 | 3,614,989 |
| 2023-01-17 | Krishnan Krish S (President and CEO) | Sale | 44,297 | 81.61 | 3,614,989 |
| 2023-01-03 | Krishnan Suma (President, R&D) | Sale | 10,200 | 80.33 | 819,366 |
| 2023-01-03 | Krishnan Krish S (President and CEO) | Sale | 6,800 | 80.33 | 546,244 |
| 2022-12-29 | Krishnan Suma (President, R&D) | Sale | 48,066 | 80.70 | 3,878,781 |
| 2022-12-29 | Krishnan Krish S (President and CEO) | Sale | 32,044 | 80.70 | 2,585,854 |
| 2022-12-16 | Krishnan Suma (President, R&D) | Sale | 21,099 | 80.10 | 1,689,987 |
| 2022-12-16 | Krishnan Krish S (President and CEO) | Sale | 21,099 | 80.10 | 1,689,987 |
| 2022-11-23 | Krishnan Suma (President, R&D) | Sale | 4 | 80.01 | 320 |
| 2022-11-08 | Krishnan Suma (President, R&D) | Sale | 1,789 | 80.05 | 143,200 |
| 2022-11-08 | Krishnan Krish S (President and CEO) | Sale | 1,789 | 80.05 | 143,200 |
| 2021-12-10 | Krishnan Suma (Chief Operating Officer) | Sale | 100,000 | 70.50 | 7,050,000 |
| 2021-12-10 | Krishnan Krish S (President and CEO) | Sale | 100,000 | 70.50 | 7,050,000 |
| 2021-12-10 | Janney Daniel (Director) | Sale | 100,000 | 70.50 | 7,050,000 |
| 2020-09-17 | Krishnan Suma (Chief Operating Officer) | Sale | 19,157 | 46.67 | 894,095 |
| 2020-09-16 | Krishnan Suma (Chief Operating Officer) | Sale | 14,891 | 46.55 | 693,116 |
| 2020-09-15 | Krishnan Suma (Chief Operating Officer) | Sale | 15,952 | 46.68 | 744,623 |
| 2020-06-15 | Krishnan Suma (Chief Operating Officer) | Sale | 50,000 | 43.28 | 2,163,900 |
| 2020-05-18 | Krishnan Krish S (President and CEO) | Sale | 23,161 | 57.86 | 1,340,072 |
| 2020-05-15 | Krishnan Krish S (President and CEO) | Sale | 26,839 | 58.18 | 1,561,519 |
| 2020-03-18 | Krishnan Suma (Chief Operating Officer) | Sale | 659 | 40.20 | 26,493 |
| 2020-03-17 | Krishnan Suma (Chief Operating Officer) | Sale | 12,180 | 41.26 | 502,546 |
| 2020-03-16 | Krishnan Suma (Chief Operating Officer) | Sale | 2,559 | 40.14 | 102,713 |
| 2020-02-20 | Krishnan Krish S (President and CEO) | Sale | 18,681 | 61.05 | 1,140,475 |
| 2020-02-19 | Krishnan Krish S (President and CEO) | Sale | 18,650 | 62.92 | 1,173,476 |
| 2020-02-18 | Krishnan Krish S (President and CEO) | Sale | 12,669 | 63.06 | 798,945 |
| 2019-12-18 | Krishnan Suma (Chief Operating Officer) | Sale | 9,112 | 61.38 | 559,340 |
| 2019-12-17 | Krishnan Suma (Chief Operating Officer) | Sale | 19,941 | 61.64 | 1,229,123 |
| 2019-12-16 | Krishnan Suma (Chief Operating Officer) | Sale | 20,947 | 64.09 | 1,342,451 |
| 2019-11-19 | Riley Antony A (Chief Financial Officer) | Option Ex | 6,250 | 9.85 | 61,562 |
| 2019-11-18 | Krishnan Krish S (President and CEO) | Sale | 22,121 | 52.74 | 1,166,727 |
| 2019-11-15 | Krishnan Krish S (President and CEO) | Sale | 27,879 | 50.63 | 1,411,458 |
| 2019-08-30 | Janney Daniel (Director) | Sale | 32,190 | 46.18 | 1,486,534 |
| 2019-08-29 | Janney Daniel (Director) | Sale | 56,494 | 47.05 | 2,658,325 |
| 2018-10-18 | Krishnan Suma (Chief Operating Officer) | Buy | 25,000 | 20.00 | 500,000 |
| 2018-10-18 | Krishnan Krish S (President and CEO) | Buy | 25,000 | 20.00 | 500,000 |
| 2018-06-06 | Krishnan Suma (Chief Operating Officer) | Buy | 14,134 | 11.80 | 166,752 |
| 2018-06-05 | Krishnan Suma (Chief Operating Officer) | Buy | 10,866 | 10.74 | 116,755 |
| 2018-05-22 | Riley Antony A (Chief Financial Officer) | Buy | 2,800 | 10.75 | 30,100 |
| 2018-05-09 | Norby R Douglas (Director) | Buy | 9,000 | 10.42 | 93,780 |
| 2018-03-19 | Krishnan Krish S (President and CEO) | Buy | 50,000 | 11.00 | 550,000 |
| 2017-09-22 | Krishnan Suma (Chief Operating Officer) | Buy | 100,000 | 10.00 | 1,000,000 |
| 2017-09-22 | Krishnan Krish S (President and CEO) | Buy | 100,000 | 10.00 | 1,000,000 |
| 2017-09-22 | Janney Daniel (Director) | Buy | 200,000 | 10.00 | 2,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of KRYS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Krystal Biotech, Inc. (symbol KRYS, CIK number 1711279) see the Securities and Exchange Commission (SEC) website.